INNOVENT BIO

01801

----

H1 2026 Earnings

Financial report interval: 2025.12.30 - 2026.06.30

Overview: INNOVENT BIO(01801) the Revenue is 9.946 B (+52.73%), Miss estimate;the EBIT is 1.272 B (+56.66%), Beat estimate;the EPS is 0.808 (--%), Beat estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueMiss expectations

9.95B52.73%

11.35B74.32%

-1.41B21.59%

EBITExceed expectations

1.27B56.66%

1.26B55.02%

+0.01B1.64%

EPSExceed expectations

0.8079--

0.5424--

+0.2655--%

Revenue

ActualEstimateUnit: HKD

Quarterly

EBIT

ActualEstimateUnit: HKD

Quarterly

Net income

ActualEstimateUnit: HKD

Quarterly

EPS

ActualEstimateUnit: HKD

Quarterly